First AD

Second AD

Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.

Zanubrutinib-Based Treatment Clinical Trial Updates

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

CURE Expert Connections

CLL: Treatment and Management Strategies for Best Outcomes

CURE Expert Connections® is a video series designed to help patients and their loved ones along their cancer care journey by offering information and expert advice from leaders in oncology care. Expert medical professionals share their knowledge and insights on an array of topics to allow for a better understanding of what to expect following a cancer diagnosis. Expert Connections hopes to bridge the gap between patients and oncology professionals to ensure no question is left unanswered.

CURE Expert Connections®

Baptist Health Cancer Care

Cancer Centers

Institution Partners

Dana-Farber

Understanding a CLL Diagnosis

Diagnostic Tests in CLL

Goals of Treatment for Patients With CLL

Current First-Line Treatment Options in CLL

Factors That Guide CLL Treatment Decisions

What to Expect from Treatment

Overview of Efficacy and Safety Data for Current CLL Treatment Options

Acalabrutinib-Based Treatment Clinical Trial Updates

Venetoclax-Based Treatment Clinical Trial Updates

Ibrutinib-Based Treatment Clinical Trial Updates

Newer Combinations for the Treatment of CLL

What to Know Before Starting Your CLL Treatment

An Overview of Potential Treatment Adverse Effects

Treatment Decisions in R/R CLL

Shared Decision-Making and Supportive Care in the CLL Treatment Journey

Optimizing Overall Health During CLL Management

Getting the Most From Your CLL Care Team

Zanubrutinib-Based Treatment Clinical Trial Updates

Latest News